Rivaroxaban for slow blood flow after heart attack stent treatment
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if adding rivaroxaban, a blood thinner, to standard care can help improve slow blood flow in heart arteries after a stent is placed. It is for people who had a severe type of heart attack (STEMI) and still have slow flow after their procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a specific type of heart attack called STEMI and received a stent (PCI)
- After the stent, doctors saw that blood flow in the treated artery was slower than normal but not completely blocked
- You sign a consent form and agree to follow the study schedule
- You do not have other serious health issues like bleeding risks, cancer with short life expectancy, kidney or liver problems, or need long-term blood thinners
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a blood thinner, rivaroxaban, to see if it can prevent blood clots from forming in the heart after a specific type of heart attack (STEMI) that affects the front part of the heart.
This trial studies whether a specific blood thinner can better treat a left-side heart clot found soon after a heart attack. It may help prevent the clot from getting worse or causing complications.
This trial tests how to use a blood thinner in people after a recent heart attack who have a clot in the left heart chamber confirmed by heart MRI. It may help lower the risk of the clot causing serious complications, but it also requires careful bleeding-safety screening.
This trial tests a blood thinner called rivaroxaban (Xarelto) given right after heart valve surgery with a tissue valve. It aims to see if it can prevent blood clots or strokes safely in the early recovery period.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests if a blood thinner called Rivaroxaban can treat a blood clot that forms in the wrist artery after a heart catheterization. If you have this clot, taking Rivaroxaban may help reopen the artery and improve blood flow.
Hear when a new ST Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.